Targeting SYK enhances responses to radiotherapy and PD-1 blockade with myeloid immune remodeling in breast cancer
Elevated SYK expression, particularly in TNBC, was associated with inferior clinical outcomes and immune dysregulation, and further investigation of SYK-targeted strategies to improve responses to combined radiotherapy and immune checkpoint blockade is supported.